Sugi Predict

Sugi Predict / Compounds / SCHEMBL6583738

SCHEMBL6583738

SCHEMBL6583738

CC(C)CC(=O)c1c(-c2ccc3c(Br)c(OCc4nnn[nH]4)ccc3c2)oc2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 6/20 0.39
▸ ANO1 Q5XXA6 6/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ GRM2 Q14416 1/20 0.34
▸ NPC1 O15118 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ PRNP P04156 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6582356 0.89 PTPN1 (0.44) PTPN1ANO1SMN1; SMN2MAPTMEN1
SCHEMBL6585048 0.87 PTPN1 (0.42) PTPN1ANO1SMN1; SMN2MAPTMEN1
SCHEMBL6584711 0.86 MEN1 (0.37) PTPN1ANO1SMN1; SMN2MAPTMEN1
SCHEMBL5341795 0.83 SMN1; SMN2 (0.34) PTPN1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL6579423 0.83 PTPN1 (0.40) PTPN1ANO1SMN1; SMN2MAPTMEN1
SCHEMBL6582762 0.80 LMNA (0.38) PTPN1ANO1SMN1; SMN2MAPTMEN1
SCHEMBL6583718 0.79 LMNA (0.36) PTPN1ANO1SMN1; SMN2MAPTMEN1
SCHEMBL6580545 0.79 SLC2A1 (0.37) PTPN1ANO1MAPTTP53RXFP1
SCHEMBL6584368 0.79 LMNA (0.35) PTPN1ANO1SMN1; SMN2MAPTHTT
SCHEMBL6585735 0.78 PTPN1 (0.33) PTPN1SMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401822-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) Wyeth (US) 2004-03-31 — — EP claimed
US-6599925-B2 Cardiovascular disorders; anticancer agents WYETH 2003-07-29 — — US claimed
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) WYETH 2003-01-23 — — US claimed
WO-2003000671-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) WYETH (US) 2003-01-03 — — WO claimed
EP-1401822-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) Wyeth (US) 2004-03-31 — — EP disclosed
US-6599925-B2 Cardiovascular disorders; anticancer agents WYETH 2003-07-29 — — US disclosed
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) WYETH 2003-01-23 — — US disclosed
WO-2003000671-A1 NAPHTHYL BENZOFURAN DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) WYETH (US) 2003-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018067-A1 Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) F2R, SERPINE1, SERPINC1 PTPN1 1287/4885ANO1 3199/4885SMN1; SMN2 4130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.